PPARG and neoplasm: The conundrum of PPARγ in colon carcinogenesis suggests that early treatment with the PPARγ agonists before the first step of carcinogenesis occurs may prevent tumor formation, but that activation of PPARγ after tumor initiation, as is the case in the APCMin mice, may promote cancer [172,177].